214 related articles for article (PubMed ID: 16863659)
21. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils.
Scapini P; Bazzoni F; Cassatella MA
Immunol Lett; 2008 Feb; 116(1):1-6. PubMed ID: 18155301
[TBL] [Abstract][Full Text] [Related]
22. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
[TBL] [Abstract][Full Text] [Related]
23. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production.
Kalled SL
Semin Immunol; 2006 Oct; 18(5):290-6. PubMed ID: 16931038
[TBL] [Abstract][Full Text] [Related]
24. The late news on baff in autoimmune diseases.
Youinou P; Pers JO
Autoimmun Rev; 2010 Oct; 9(12):804-6. PubMed ID: 20656068
[TBL] [Abstract][Full Text] [Related]
25. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F; Schneider P
Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
[TBL] [Abstract][Full Text] [Related]
26. sBAFF mutants induce neutralizing antibodies against BAFF.
Gao H; Bian A; Zheng Y; Li R; Ji Q; Huang G; Hu D; Zhang L; Gong W; Hu Y; He F
FEBS Lett; 2007 Feb; 581(4):581-6. PubMed ID: 17257595
[TBL] [Abstract][Full Text] [Related]
27. Regulation of B cell self-tolerance by BAFF.
Brink R
Semin Immunol; 2006 Oct; 18(5):276-83. PubMed ID: 16916609
[TBL] [Abstract][Full Text] [Related]
28. BAFF - an essential survival factor for B cells: Links to genesis of ITP and may be of therapeutic target.
Yu HM; Liu YF; Hou M
Med Hypotheses; 2008; 70(1):40-2. PubMed ID: 17592744
[TBL] [Abstract][Full Text] [Related]
29. Travelling with the BAFF/BLyS family: are we there yet?
Mackay F; Cancro MP
Semin Immunol; 2006 Oct; 18(5):261-2. PubMed ID: 16905331
[No Abstract] [Full Text] [Related]
30. The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity.
Cancro MP
Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii34-6. PubMed ID: 17038469
[TBL] [Abstract][Full Text] [Related]
31. Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease.
Fabris M; Visentini D; De Re V; Picierno A; Maieron R; Cannizzaro R; Villalta D; Curcio F; De Vita S; Tonutti E
Scand J Gastroenterol; 2007 Dec; 42(12):1434-9. PubMed ID: 17852877
[TBL] [Abstract][Full Text] [Related]
32. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
33. B-cell targeted therapies in human autoimmune diseases: an updated perspective.
Townsend MJ; Monroe JG; Chan AC
Immunol Rev; 2010 Sep; 237(1):264-83. PubMed ID: 20727041
[TBL] [Abstract][Full Text] [Related]
34. Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review.
Lied GA; Berstad A
Scand J Immunol; 2011 Jan; 73(1):1-7. PubMed ID: 21128997
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
[TBL] [Abstract][Full Text] [Related]
36. An APRIL to remember: novel TNF ligands as therapeutic targets.
Dillon SR; Gross JA; Ansell SM; Novak AJ
Nat Rev Drug Discov; 2006 Mar; 5(3):235-46. PubMed ID: 16474316
[TBL] [Abstract][Full Text] [Related]
37. Integration of signals mediated by B-cell receptor, B-cell activating factor of the tumor necrosis factor family (BAFF) and Fas (CD95).
Hancz A; Hérincs Z; Neer Z; Sármay G; Koncz G
Immunol Lett; 2008 Mar; 116(2):211-7. PubMed ID: 18243342
[TBL] [Abstract][Full Text] [Related]
38. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
Levesque MC; St Clair EW
J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
[TBL] [Abstract][Full Text] [Related]
39. cDNA cloning, expression and bioactivity of porcine BAFF.
Guan ZB; Dan WB; Shui Y; Ye JL; Zhang SQ
Dev Comp Immunol; 2007; 31(12):1211-9. PubMed ID: 17499850
[TBL] [Abstract][Full Text] [Related]
40. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
